Berman Capital Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History

Berman Capital Advisors’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-14	Closed	-$2K	–	2312
2021 Q2	$2K	Buy	14 +2	+17%	+$334	﹤0.01%	1673
2021 Q1	$1K	Sell	12 -3	-20%	-$407	﹤0.01%	1742
2020 Q4	$1K	Hold	15	–	–	﹤0.01%	1642
2020 Q3	$1K	Sell	15 -6	-29%	-$612	﹤0.01%	1564
2020 Q2	$2K	Buy	+21	New	+$1.95K	﹤0.01%	1356

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Berman Capital Advisors's PRAH Position: Q3 2021 in Review

Berman Capital Advisors sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 14 shares — an estimated $2K sold.

Berman Capital Advisors first reported a position in PRAH in Q2 2020 and held it in 5 quarters. The position peaked at $2K in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Berman Capital Advisors reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Berman Capital Advisors sold 14 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $2K.
Berman Capital Advisors first reported a position in PRA Health Sciences, Inc. in Q2 2020 and held it in 5 quarters.
Berman Capital Advisors's PRA Health Sciences, Inc. position peaked at $2K in Q2 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.